Polar Capital’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-10,476
Closed -$16.9K 276
2018
Q2
$16.9K Buy
10,476
+185
+2% +$298 0.1% 168
2018
Q1
$16.7M Buy
10,291
+3,498
+51% +$5.68M 0.17% 149
2017
Q4
$11.4M Buy
+6,793
New +$11.4M 0.12% 155
2015
Q1
Sell
-160
Closed -$115K 287
2014
Q4
$115K Buy
+160
New +$115K ﹤0.01% 274